Online citations, reference lists, and bibliographies.

HA-coated Chitosan Nanoparticles For CD44-mediated Nucleic Acid Delivery.

Abdulaziz Almalik, P. Day, N. Tirelli
Published 2013 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
CD44, the main receptor of hyaluronic acid (HA), is overexpressed in several pathological conditions and therefore can be seen as an interesting target for therapeutic intervention. Here, an approach using HA-coated chitosan (CS)-triphosphate (TPP) nanoparticles is investigated, using CS with different molecular weight (25 and 684 kDa), which influences HA presentation, and enzymatic and pH stability. In a study of nuclease stability, post-digestion of nanoparticles with chitosanase reveals that pDNA is at least partially degraded by DNAse; this may suggest that literature results overestimate the polyplex stability against nucleases. Using cells with a significantly different CD44 expression (RAW 264.7 macrophages-high levels; K562 leukemia cells-low levels; Kelly neuroblastoma cells-absent), the selectivity of CD44-mediated transfection is proven. Further, using luciferase pDNA and then later anti-luc siRNA, low MW CS-based nanoparticles show the best results despite a lower internalization efficiency; this effect is ascribed to a more efficient endosomal disruption and nucleic acid de-complexation.
This paper references
10.1517/14728222.2012.687374
CD44: a validated target for improved delivery of cancer therapeutics
S. Ghosh (2012)
10.1016/J.JCONREL.2005.05.004
Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation.
M. Huang (2005)
10.1016/J.BIOMATERIALS.2006.08.046
Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery.
P. Chan (2007)
10.1016/J.BIOMATERIALS.2006.11.004
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
X. Liu (2007)
Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
N. Gross (1997)
10.1128/MCB.11.11.5446
Expression of CD44 is repressed in neuroblastoma cells.
E. Shtivelman (1991)
10.1016/j.jconrel.2011.10.008
Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response.
Yifat Glucksam-Galnoy (2012)
10.1016/J.JCONREL.2006.04.014
Toxicity of cationic lipids and cationic polymers in gene delivery.
Hongtao Lv (2006)
10.1007/s00439-013-1288-1
Silencing human genetic diseases with oligonucleotide-based therapies
T. Martínez (2013)
10.1023/A:1014861900478
A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity
D. Fischer (2004)
10.1002/ADFM.201000177
Functionalization of Chitosan via Atom Transfer Radical Polymerization for Gene Delivery
Yuan Ping (2010)
10.1007/s11095-009-9908-0
Chitosan/TPP and Chitosan/TPP-hyaluronic Acid Nanoparticles: Systematic Optimisation of the Preparative Process and Preliminary Biological Evaluation
A. Nasti (2009)
10.1021/BM050912Z
Design of biocompatible chitosan microgels for targeted pH-mediated intracellular release of cancer therapeutics.
H. Zhang (2006)
10.1016/S0939-6411(03)00155-3
Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy.
Sania Mansouri (2004)
10.1038/cgt.2008.8
Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
A. Tong (2008)
Plasma membrane targeting of SNAP-25 increases its local concentration and is necessary for SNARE complex formation and regulated exocytosis.
D. Koticha (2002)
10.1023/A:1011930127562
Long-Circulating Nanopartides Bearing Heparin or Dextran Covalently Bound to Poly(Methyl Methacrylate)
C. Passirani (2004)
10.1517/17425241003730399
Nanostructured hyaluronic acid-based materials for active delivery to cancer
D. Ossipov (2010)
10.1038/nrg1577
Towards safe, non-viral therapeutic gene expression in humans
D. Glover (2005)
Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells
Laura Contreras-Ruiz (2011)
10.1182/BLOOD-2005-09-3808
CD44 is a phagocytic receptor.
Eric Vachon (2006)
10.1023/A:1011037807261
Water-Soluble and Low Molecular Weight Chitosan-Based Plasmid DNA Delivery
M. Lee (2004)
10.1016/J.EJPB.2005.02.011
Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.
Shuying Gao (2005)
10.1517/14712598.2013.758709
Therapeutic and prophylactic DNA vaccines for HIV-1
L. Ramirez (2013)
Gene expression profiling in chemoresistant variants of three cell lines of different origin.
A. Johnsson (2005)
10.1038/nbt0597-462
In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer
C. K. Goldman (1997)
10.1016/j.biomaterials.2013.03.065
Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles.
Abdulaziz Almalik (2013)
10.1016/S0168-3659(00)00361-8
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
H. Mao (2001)
10.1038/nri1459
Gene therapy for autoimmune diseases: quo vadis?
Y. Chernajovsky (2004)
10.1016/j.addr.2009.08.004
Chitosan-based formulations for delivery of DNA and siRNA.
S. Mao (2010)
10.1084/jem.182.2.419
Glycosylation of CD44 negatively regulates its recognition of hyaluronan
S. Katoh (1995)
10.1167/iovs.07-1077
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
M. de la Fuente (2008)
10.1021/mp900093r
Biological barriers to therapy with antisense and siRNA oligonucleotides.
R. Juliano (2009)
10.2741/3506
Macrophages and fibroblasts during inflammation, tissue damage and organ injury.
T. Glaros (2009)
10.1016/j.biomaterials.2009.07.012
Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine.
Peisheng Xu (2009)
10.1002/mabi.201100156
Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model.
N. M. Zaki (2011)
10.1007/s11095-010-0263-y
Hyaluronic Acid/Chitosan-g-Poly(ethylene glycol) Nanoparticles for Gene Therapy: An Application for pDNA and siRNA Delivery
M. Raviña (2010)
10.1016/j.ejps.2010.03.019
Gene delivery by lipoplexes and polyplexes.
C. Tros de Ilarduya (2010)
10.1007/s11095-006-9136-9
Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery
D. Lee (2006)
10.1046/j.1365-2141.1998.00543.x
Comparative adhesion of human haemopoietic cell lines to extracellular matrix components, bone marrow stromal and endothelial cultures
M. Turner (1998)
10.1074/jbc.M110.102640
The Transmembrane Domains of L-selectin and CD44 Regulate Receptor Cell Surface Positioning and Leukocyte Adhesion under Flow*
K. Buscher (2010)
10.1517/14712598.4.7.1103
Intravenous, non-viral RNAi gene therapy of brain cancer
W. Pardridge (2004)
10.1166/JNN.2006.434
Receptor-mediated gene delivery into antigen presenting cells using mannosylated chitosan/DNA nanoparticles.
T. Kim (2006)
10.1038/nature07758
The promises and pitfalls of RNA-interference-based therapeutics
D. Castanotto (2009)
Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes.
S. Katoh (1999)
10.1016/S0378-5173(03)00082-6
Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting.
Shuying Gao (2003)



This paper is referenced by
10.1002/adhm.201500941
Mannosylation Allows for Synergic (CD44/C-Type Lectin) Uptake of Hyaluronic Acid Nanoparticles in Dendritic Cells, but Only upon Correct Ligand Presentation.
A. Gennari (2016)
10.1016/j.ijbiomac.2016.04.070
Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
M. A. Kalam (2016)
10.1016/j.biomaterials.2015.02.071
Nanoparticle delivery of stable miR-199a-5p agomir improves the osteogenesis of human mesenchymal stem cells via the HIF1a pathway.
X. Chen (2015)
10.1007/s10856-018-6160-3
Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta
Rong-Hui Deng (2018)
10.1021/acs.biomac.5b00221
Tailoring the Surface of a Gene Delivery Vector with Carboxymethylated Dextran: A Systematic Analysis.
Charles Fortier (2015)
10.1038/mtna.2015.13
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia.
Breanne Landry (2015)
10.1016/j.ijpharm.2014.12.047
Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitis C by RNA interference.
J. Torrecilla (2015)
10.1016/j.ijpharm.2014.10.061
Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: in vitro and in vivo investigations.
Sobiya Zafar (2014)
10.1021/acs.molpharmaceut.6b00078
Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells.
Vivek D Badwaik (2016)
10.1002/BKCS.11080
1H‐NMR‐based Metabolomics Studies of the Toxicity of Mesoporous Carbon Nanoparticles in Zebrafish (Danio rerio)
Ganesan Raja (2017)
10.1002/PI.5702
Saccharide‐based nanocarriers for targeted therapeutic and diagnostic applications
Vincent Mukwaya (2019)
10.1016/j.ijpharm.2019.02.032
CD44 targeted delivery of siRNA by using HA‐decorated nanotechnologies for KRAS silencing in cancer treatment
Annalisa Tirella (2019)
10.1039/c8tx00041g
Cellular responses of hyaluronic acid-coated chitosan nanoparticles.
Abdulaziz M Almalik (2018)
10.3390/molecules25051071
On the Formation and Stability of Chitosan/Hyaluronan-Based Complex Coacervates
Franco Furlani (2020)
HA-decorated nanoparticles as tumour-targeting nucleic acids carriers
J. L. Rosa (2015)
10.1007/s11051-020-04838-2
Targeted delivery of a short antimicrobial peptide against CD44-overexpressing tumor cells using hyaluronic acid-coated chitosan nanoparticles: An in vitro study
Vahid Taghipour-Sabzevar (2020)
10.1002/adbi.201800049
Receptor‐Targeted Drug Delivery and the (Many) Problems We Know of: The Case of CD44 and Hyaluronic Acid
Julio M. Rios de la Rosa (2018)
10.3390/gels4030067
Concepts for Developing Physical Gels of Chitosan and of Chitosan Derivatives
Pasquale Sacco (2018)
10.1016/j.ejpb.2018.01.009
Development and characterisation of chondroitin sulfate‐ and hyaluronic acid‐incorporated sorbitan ester nanoparticles as gene delivery systems
I. Fernandez-Piñeiro (2018)
10.3390/nu10091304
Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity
V. Quagliariello (2018)
10.1021/acs.molpharmaceut.7b00320
Chitosan/Hyaluronic Acid Nanoparticles: Rational Design Revisited for RNA Delivery.
E. Lallana (2017)
10.1002/adhm.201901182
Binding and Internalization in Receptor-Targeted Carriers: The Complex Role of CD44 in the Uptake of Hyaluronic Acid-Based Nanoparticles (siRNA Delivery).
Julio M Rios de la Rosa (2019)
10.3762/bjnano.10.250
The different ways to chitosan/hyaluronic acid nanoparticles: templated vs direct complexation. Influence of particle preparation on morphology, cell uptake and silencing efficiency
A. Gennari (2019)
10.1016/j.ijbiomac.2014.09.005
Hyaluronic acid decorated lipid nanocarrier for MDR modulation and CD-44 targeting in colon adenocarcinoma.
Lalit Mohan Singh Negi (2015)
10.1155/2017/6971297
Targeted Delivery of siRNA Therapeutics to Malignant Tumors
Qixin Leng (2017)
Développement de complexes polyélectrolytes à base d’acide hyaluronique et de chitosane pour la livraison d’ARN messager
Ousamah Younoss Soliman (2018)
10.1016/j.carbpol.2019.01.068
Synergistic clearance of intracellular pathogens by hyaluronan-streptomycin micelles encapsulated with rapamycin.
Yuanhao Qiu (2019)
10.1002/jcp.25283
New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase
V. Quagliariello (2016)
10.7314/APJCP.2014.15.12.4773
BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia.
X. Zhu (2014)
10.1002/adhm.201601012
The CD44‐Mediated Uptake of Hyaluronic Acid‐Based Carriers in Macrophages
Julio M. Rios de la Rosa (2017)
10.3390/pharmaceutics10040267
The Microfluidic Technique and the Manufacturing of Polysaccharide Nanoparticles
E. Chiesa (2018)
10.1248/bpb.b14-00478
Splenic gene delivery system using self-assembling nano-complex with phosphatidylserine analog.
Tomoaki Kurosaki (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar